← Back to Search

Family Service Navigation for Autism

N/A
Recruiting
Led By Meghan Burke, PhD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be age 18 or older,
Be English speaking or Spanish-speaking,
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the pre-survey and at the three-month, six-month, and nine-month survey
Awards & highlights

Study Summary

This trialtests a training program and app to help families of young kids (3-5) with autism access needed services.

Who is the study for?
This trial is for English-speaking parents, aged 18 or older, from low-resourced communities. They must have a young child (aged 3-5) with autism and want help navigating service systems. Participants need to own or be provided a phone compatible with the treatment support app.Check my eligibility
What is being tested?
The study is evaluating a program where trained Family Service Navigators use an app to assist families in accessing services for children with autism. It aims to see if this support improves service access for these families.See study design
What are the potential side effects?
Since this trial involves educational and technological interventions rather than medical treatments, traditional physical side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I speak English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the pre-survey and at the nine-month survey
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the pre-survey and at the nine-month survey for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Adaptive and maladaptive behavior at 9 months
Change in Advocacy at 9 months
Change in Empowerment at 9 months
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group (Access to an FSN/TSS)Experimental Treatment1 Intervention
40 participants will be randomly assigned to the intervention group (i.e., to receive an FSN and have access to the TSS). The FSN may meet with the participant at least twice and provide navigation support.
Group II: Control Group (Access to Information, training and referral)Active Control1 Intervention
15 participants will be randomly assigned to the non-personalized comparison group (i.e., information, training, and referral).

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
704 Previous Clinical Trials
6,143,308 Total Patients Enrolled
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,280 Total Patients Enrolled
Meghan Burke, PhDPrincipal InvestigatorVanderbilt University

Media Library

Family Service Navigator Program Clinical Trial Eligibility Overview. Trial Name: NCT05099705 — N/A
Mental Health Services Research Study Groups: Intervention Group (Access to an FSN/TSS), Control Group (Access to Information, training and referral)
Mental Health Services Clinical Trial 2023: Family Service Navigator Program Highlights & Side Effects. Trial Name: NCT05099705 — N/A
Family Service Navigator Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05099705 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total recruitment target for this medical trial?

"Affirmative. According to the information on clinicaltrials.gov, this investigation is currently recruiting participants. The trial was first posted on July 1st 2022 and has been revised most recently on October 27th 2022; 55 patients are needed at a single medical site."

Answered by AI

Is enrollment currently available for this experiment?

"Affirmative, the trial is still recruiting candidates. The clinical research was launched on July 1st 2022 and has since been revised as recent as October 27th 2022. 55 participants will be accepted from a single site."

Answered by AI
~20 spots leftby Apr 2025